G + FLAS Life Sciences
Developing gene editing technologies for new drugs and plant-based biopharmaceuticals. It focuses on CRISPR-CasN enzymes and CRISPR gene editing to create innovative solutions in healthcare and agriculture. The offerings include CRISPR genome editing, CRISPR services, and protein synthesis. They are developing new drugs, plant-based biopharmaceuticals, and novel crop varieties enriched with vitamins and nutrients.…
Funding snapshot
About
Developing gene editing technologies for new drugs and plant-based biopharmaceuticals. It focuses on CRISPR-CasN enzymes and CRISPR gene editing to create innovative solutions in healthcare and agriculture. The offerings include CRISPR genome editing, CRISPR services, and protein synthesis. They are developing new drugs, plant-based biopharmaceuticals, and novel crop varieties enriched with vitamins and nutrients. It utilizes platforms like Cancerase for cancer therapeutics and PDB for plant-bas Founded in 2014, headquartered in Cheongju-si, South Korea. The company has raised $12M at the Series C stage backed by investors including Smile Gate Investment, Chong Kun Dang Pharmaceutical, Alpen Route, ActnerLab, E&Investment. Operating in Life Sciences > Life Sciences Platforms and Tools, Food and Agriculture Tech > Crop Tech.
Business model
Genomics > Enabling Technologies > Technology Platforms > Gene Editing,
Life Sciences Platforms and Tools > Research Services > Diversified,
Crop Tech > Farm Inputs > Plant Breeding > Technology Providers
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like G + FLAS Life Sciences?
Analyze your pitch deck before your next raise.
Analyze My Deck →